In most cases, cancer cells exhibit dysfunctional mitochondrial enzymes favoring oncogenic effects, affecting hypoxia-inducible factor 1 (HIF-1α) activation as well as genomic instability (via ROS production and mutations of mtDNA). This evidence concerns the gene HIF1A and cancer.